Label: LORATADINE tablet, orally disintegrating

  • NDC Code(s): 72983-501-01, 72983-501-03
  • Packager: Tenshi Kaizen Pvt Ltd
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated January 2, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient (in each tablet)

    Loratadine 10 mg

  • Purpose

    Antihistamine

  • Uses

    temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

    • runny nose
    • itchy, watery eyes
    • sneezing
    • itching of the nose or throat
  • Warnings

    Do not use if you have ever had an allergic reaction to this product or any of its ingredients.

    Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

    When using this product do not take more than directed. Taking more than directed may cause drowsiness.

    Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    • place 1 tablet on tongue; tablet disintegrates, with or without water
    adults and children 6 years and over1 tablet daily; not more than 1 tablet in 24 hours
    children under 6 years of ageask a doctor
    consumers with liver or kidney diseaseask a doctor

  • Other information

    • safety sealed: do not use if the individual blister unit imprinted with Loratadine Orally Disintegrating Tablet, USP is open or torn
    • store between 20° to 25°C (68° to 77°F)
    • use tablet immediately after opening individual blister
    • complies with USP Procedure 2 for Assay and Organic Impurities and Test 2 for Disintegration
  • Inactive ingredients

    anhydrous citric acid, mannitol, peppermint flavor, polysorbate 80, pullulan

  • Questions or comments?

    1-877-244-9825

  • SPL UNCLASSIFIED SECTION

    Manufactured by:

    Tenshi Kaizen Private Limited

    Bengaluru Rural – 562112, India

    Revised: 01/2023

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    NDC 72983-501-01

    Non-Drowsy*

    Loratadine Orally Disintegrating Tablets USP, 10 mg

    antihistamine

    Indoor & Outdoor

    Allergies

    *When taken as directed. See Drug Facts Panel.

    24 Hour Relief of:

    Sneezing

    Runny Nose

    Itchy, Watery Eyes

    Itchy Throat or Nose

    No Water Needed

    Melts in Your Mouth

    10

    ORALLY

    DISINTEGRATING TABLETS

    label

  • INGREDIENTS AND APPEARANCE
    LORATADINE 
    loratadine tablet, orally disintegrating
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72983-501
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN) LORATADINE10 mg
    Inactive Ingredients
    Ingredient NameStrength
    ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
    PULLULAN (UNII: 8ZQ0AYU1TT)  
    POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
    MANNITOL (UNII: 3OWL53L36A)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeROUNDSize12mm
    FlavorMINTImprint Code T10
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72983-501-033 in 1 CARTON05/19/2021
    130 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:72983-501-011 in 1 CARTON05/19/2021
    210 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21329405/19/2021
    Labeler - Tenshi Kaizen Pvt Ltd (675478488)
    Establishment
    NameAddressID/FEIBusiness Operations
    Tenshi Kaizen Pvt Ltd675478488analysis(72983-501) , manufacture(72983-501) , pack(72983-501)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!